Description
Referenced Citations
- Corpas, E., et al. (1993). “Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.” Journal of Clinical Endocrinology & Metabolism, 76(5), 1344-1348. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/8496328/ - Khorram, O., et al. (1997). “Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women.” Journal of Clinical Endocrinology & Metabolism, 82(11), 3590-3596. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/9360513/ - Vittone, J., et al. (1997). “Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.” Metabolism, 46(1), 89-96. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/9005976/ - Stier, H., et al. (2013). “Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans.” Journal of Endocrinology and Metabolism, 3(1-2), 7-15. [Online].
Available: https://jofem.org/index.php/jofem/article/view/157/194 - Walker, R.F., et al. (1994). “Growth hormone secretion in healthy elderly men: assessment by deconvolution analysis and approximate entropy algorithm.” American Journal of Physiology, 267(1 Pt 1), E150-E157. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/8048505/ - Villalobos, C., et al. (1997). “Somatostatin and GHRH: synthesis, receptors, and intracellular signaling.” Trends in Endocrinology & Metabolism, 8(10), 390-397. [Online].
Available: https://pubmed.ncbi.nlm.nih.gov/18406829/